Akèy › Ateroskleroz
Etid klinik pou Ateroskleroz ap rekrite nan Etazini
41 etid pou Ateroskleroz ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX10 etid
- Boston, MA10 etid
- Washington, DC9 etid
- Arlington, VA8 etid
- Hialeah, FL8 etid
- Orlando, FL8 etid
- Miami, FL7 etid
- Memphis, TN7 etid
- Durham, NC7 etid
- Las Vegas, NV7 etid
- Dallas, TX7 etid
- Los Angeles, CA6 etid
- Amarillo, TX6 etid
- Santa Monica, CA6 etid
- Minneapolis, MN6 etid
- San Diego, CA6 etid
- The Woodlands, TX6 etid
- Omaha, NE6 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- St. Louis, MO5 etid
- Meridian, ID5 etid
- Pittsburgh, PA5 etid
- Tucson, AZ5 etid
- Charlotte, NC5 etid
- Hollywood, FL5 etid
- San Antonio, TX5 etid
- Alexandria, VA5 etid
- Richmond, VA5 etid
- Winston-Salem, NC5 etid
- Phoenix, AZ5 etid
- Tampa, FL5 etid
- Huntsville, AL5 etid
- Jacksonville, FL5 etid
- Cincinnati, OH5 etid
- Torrance, CA5 etid
- Raleigh, NC5 etid
- Deltona, FL4 etid
- Kirkland, WA4 etid
- Atlanta, GA4 etid
Pa eta
- Alabama8 etid
- Arizona6 etid
- Arkansas3 etid
- Colorado6 etid
- Connecticut5 etid
- Florid11 etid
- Georgia8 etid
- Idaho5 etid
- Illinois8 etid
- Indiana8 etid
- Iowa5 etid
- Kalifòni14 etid
- Kansas5 etid
- Kentucky4 etid
- Lwizyàn6 etid
- Maryland12 etid
- Massachusetts11 etid
- Michigan7 etid
- Minnesota6 etid
- Mississippi4 etid
- Missouri8 etid
- Nebraska7 etid
- Nevada7 etid
- New Jersey6 etid
- New Mexico4 etid
- New York9 etid
- North Carolina12 etid
- Ohio8 etid
- Pennsylvania11 etid
- Rhode Island3 etid
- South Carolina6 etid
- South Dakota3 etid
- Tennessee9 etid
- Texas11 etid
- Utah8 etid
- Virginia9 etid
- Washington6 etid
- West Virginia4 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Causes and Natural History of Dyslipidemias
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT00353782A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07448038New Heart Imaging Techniques to Evaluate Possible Heart Disease
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01399385Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07594392Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 1 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143454A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Ap rekriteFaz 3
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143480Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Detecting Peripheral Artery Disease With the Pulse
Ap rekriteVolontè an sante akeyi
Laj 19 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07226193Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 100 · Tout sèks · Mizajou Sep 8, 2026 · NCT03581318PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study)
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07800481A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT07704918Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911Pelacarsen Roll-over Extension Program
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06471036The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Ap rekriteEtid obsèvasyon
Laj 35 a 79 · Tout sèks · Mizajou Jul 14, 2026 · NCT07315997PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT05994014Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
Ap rekrite
Laj 65 a 84 · Tout sèks · Mizajou Jun 8, 2026 · NCT05867381Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
Ap rekriteVolontè an sante akeyi
Laj 30 a 65 · Tout sèks · Mizajou Jun 3, 2026 · NCT04496947High Protein Diet and Atherosclerosis
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou May 11, 2026 · NCT05235464Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.